Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Eton Pharmaceuticals, Inc.

NASDAQ: ETON · Life Sciences · 10 alerts · CIK 1710340

Eton Pharmaceuticals, Inc. stories on ALFA USA NewsRead the news →
Share price
$63.88Close, Nov 16
Market cap
$1.84B
Shares outstanding
28.84MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Eton Pharmaceuticals, Inc. filings on SEC EDGAR ↗

7:15 AM ET 8-K
M&A Deal

Eton Pharmaceuticals Signs $10M M&A Deal with Aquestive Therapeutics, Inc.

Eton Pharmaceuticals acquired exclusive U.S. rights to commercialize LIBERVANT (diazepam) buccal film from Aquestive Therapeutics for an upfront fee of $10 million and up to $47.5 million in milestones. The deal includes a 20-year supply agreement and targets the $450 million annual U.S. seizure rescue market with an anticipated launch in April 2027.

Value
$10M
Counterparty
Aquestive Therapeutics, Inc.
Term
20 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.